Deep Tech Startups

Iris Automation develops AI-based computer vision software that provides collision avoidance for autonomous industrial drones. The company targets enabling safer beyond-visual-line-of-sight drone operations.

7 investors

Kakarot builds a zero-knowledge (ZK) proving engine for the Ethereum Virtual Machine (EVM), aimed at verifying digital data. The project is joining Zama.

7 investors

Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a genetic payload for gene-editing and other DNA-based therapies, offering an alternative to viral vectors and double-stranded DNA. It manufactures cssDNA via industrial fermentation and licenses and supplies the payload to therapeutic developers through integrated partnerships spanning discovery to GMP.

7 investors

Kapta develops an electronically scanned (metasurface-based) synthetic aperture radar sensor deployed on satellites to provide large-area, low-latency geospatial intelligence and InSAR change-detection data. It serves commercial markets such as mining, energy, and transportation as well as defense customers needing moving-target indication and threat tracking.

7 investors

Kayhan Space develops technology to improve the safety of spaceflight operations. The company operates in the space industry.

7 investors

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection. Its platforms serve cell therapy researchers and developers, supporting drug discovery, process optimization, and scaling from small-volume experiments to manufacturing.

7 investors

Landsdowne Labs develops button battery technology that deactivates batteries after accidental ingestion to address health risks. The company commercializes advanced material science solutions for global manufacturers.

7 investors

Last Energy develops modular micro nuclear power plants designed to reduce deployment time and cost. The company targets decarbonization of global energy production and increased access to reliable power through scaled nuclear technology.

7 investors

Latent Labs develops generative AI models for protein design and builds biological platforms to validate AI-driven designs. The company works at the intersection of generative AI, engineering, and biology.

7 investors

Locus Lock designs software-defined GNSS receivers for accurate positioning in complex environments including deep urban, contested, and dynamic platforms for defense and commercial applications. The technology provides high precision, configurability, and security against spoofing and jamming.

7 investors

Lumilens develops photonics-based optical interconnect technology to support the scaling of AI infrastructure and data centers, addressing the limits of electrical and legacy optical interconnects for scale-out and scale-up architectures. It also uses custom robotics and AI-optimized production processes to manufacture its products.

7 investors

Lunasonde develops aerial georadiotomography (aGRT) technology that uses low-frequency radar to create 3D compositional images of the subsurface from aircraft, helicopters, drones, and balloons. The company serves mining and resource exploration industries seeking to locate critical minerals and clean energy deposits with minimal environmental impact.

7 investors

Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.

7 investors

Mainspring Energy develops power generation systems. The company focuses on technology for utility and data center customers.

7 investors

Mapped builds a knowledge graph and world model of physical spaces, people, and things that serves as the data foundation for Physical AI applications to understand and operate in the built environment.

7 investors

Marama Labs develops optical spectroscopy instruments for life-sciences research, leveraging surface-enhanced Raman spectroscopy and nanoparticle characterization technology. The company serves research institutions and scientific laboratories requiring advanced instrumentation for molecular analysis.

7 investors

Menten AI develops generative AI software to design cyclic peptide therapeutics for drug targets beyond the reach of conventional small molecules and biologics. The company partners with major pharmaceutical firms to accelerate preclinical drug discovery.

7 investors

Merge Labs is a research lab developing brain-computer interfaces that connect with neurons using molecules instead of electrodes and non-invasive modalities like ultrasound, integrated with AI. It aims initially to help patients with injury or disease and later to broadly advance human capability.

7 investors

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

7 investors

Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders. It uses multiple neurobiology models and computational biology to study neuroimmune mechanisms and discover new therapies for patients affected by neurological disease.

7 investors

Movellus develops infrastructure IP for high-performance, energy-efficient silicon, offering solutions for clocking, droop detection, and power management. It serves semiconductor and chip designers building AI-era hardware.

7 investors

NearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications. The device is positioned for use in clinical diagnostics, sports medicine, and cardiovascular health assessment.

7 investors

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

7 investors

NextSilicon develops software-defined hardware architecture for high-performance computing in scientific research, enabling developers to accelerate existing code without rewrites or vendor lock-in. The company targets researchers in fields including cancer therapy, physics, and cosmology.

7 investors